2 weeks ago, my family was struck with unimaginable sorrow—losing both my father-in-law and his sister to Alzheimer’s in the span of a single week. My mother-in-law has been in a care home for over six years, and my dear mother is walking her own difficult journey with this illness, her condition growing heavier with each passing day. The weight of this disease has settled deep into our lives, and with no cure in sight, my heart has been set on finding something—anything—that might bring comfort or relief to those who suffer. For more than six years, my husband poured his love into visiting his dad three times a week, staying for three hours each time. Watching that slow, painful decline broke our hearts. Knowing Alzheimer’s runs on both sides of his family, I’ve felt an urgent need to protect our minds as best we can. That’s why we’ve been taking Brain Sense daily for over two years—it’s been a small but meaningful light in the darkness.
Now, I’ve stumbled across something that’s sparked a flicker of hope: a little pocket-sized VIBE Pocket PEMF Device (World's First) I recently ordered. Studies suggest that 40 Hz stimulation might hold real promise for Alzheimer’s, and that possibility feels like a gift after so much loss. This Friday, I’ll be with my mom for 10 days, caring for her and bringing this device along. I’m holding onto hope that it might ease her struggle, even just a little. When I return, I’ll share how it went—I’d love for this to be a step toward helping her and others who are facing this cruel disease alongside us.
Read More below about the Promising New Studies
Now, I’ve stumbled across something that’s sparked a flicker of hope: a little pocket-sized VIBE Pocket PEMF Device (World's First) I recently ordered. Studies suggest that 40 Hz stimulation might hold real promise for Alzheimer’s, and that possibility feels like a gift after so much loss. This Friday, I’ll be with my mom for 10 days, caring for her and bringing this device along. I’m holding onto hope that it might ease her struggle, even just a little. When I return, I’ll share how it went—I’d love for this to be a step toward helping her and others who are facing this cruel disease alongside us.
Read More below about the Promising New Studies
MIT Study Supports the VIBE Alzheimer’s protocol
April 23, 2024 by Resona Health
The VIBE Alzheimer’s protocol has been developed over 35 years from 8000 practitioners and uses 40Hz extensively in the protocol.
MIT now agrees 40Hz is very promising for Alzheimer’s:
MIT’s research on 40 Hz stimulation and Alzheimer’s disease has yielded several key conclusions:
Promising Therapeutic Potential: Studies suggest that 40 Hz stimulation has promising therapeutic potential for Alzheimer’s disease. By externally inducing gamma oscillations at this frequency, researchers aim to improve cognitive function and potentially slow the progression of the disease.
Effects on Neural Activity: Research has shown that 40 Hz stimulation can modulate neural activity, particularly in brain regions associated with memory and cognitive function. This modulation may help restore aberrant neural circuits and synaptic plasticity observed in Alzheimer’s disease.
Preclinical Efficacy: Preclinical studies, including those conducted in mouse models of Alzheimer’s, have demonstrated positive effects of 40 Hz stimulation on memory, synaptic function, and amyloid-beta pathology. These findings support further exploration of this intervention in clinical settings.
Mechanistic Insights: MIT’s research has provided valuable insights into the underlying mechanisms by which 40 Hz stimulation may exert its therapeutic effects in Alzheimer’s disease. This includes effects on neural circuitry, synaptic plasticity, and clearance of amyloid-beta plaques.
Human Trials: MIT has been involved in human trials to assess the safety and efficacy of 40 Hz stimulation in individuals with Alzheimer’s disease. While results from these trials are still emerging, initial findings suggest potential benefits for cognitive function and disease progression. A pair of early-stage clinical studies testing the safety and efficacy of 40-hertz sensory stimulation to treat Alzheimer’s disease has found that the potential therapy was well-tolerated, produced no serious adverse effects, and was associated with some significant neurological and behavioral benefits among a small cohort of participants.
Conclusion
Overall, MIT’s studies on 40 Hz stimulation and Alzheimer’s disease highlight the importance of gamma frequency oscillations in cognitive function and the potential of targeted stimulation as a therapeutic approach for Alzheimer’s disease.
Most recently, in pilot clinical studies the team showed that 40 Hz light and sound stimulation was safe, successfully increased brain activity and connectivity, and appeared to produce significant clinical benefits in a small cohort of human volunteers with early-stage Alzheimer’s disease. Other groups have replicated and corroborated health benefits of 40 Hz sensory stimulation.
Latest News is even Better ~ March 3, 2025
Review: Evidence expanding that 40Hz gamma stimulation promotes brain health
Indeed the review points to studies at MIT and other institutions providing at least some evidence that GENUS might be able to help with Parkinson’s disease, stroke, anxiety, epilepsy, and the cognitive side effects of chemotherapy and conditions that reduce myelin such as multiple sclerosis. Tsai’s lab has been studying whether it can help with Down syndrome as well.
April 23, 2024 by Resona Health
The VIBE Alzheimer’s protocol has been developed over 35 years from 8000 practitioners and uses 40Hz extensively in the protocol.
MIT now agrees 40Hz is very promising for Alzheimer’s:
MIT’s research on 40 Hz stimulation and Alzheimer’s disease has yielded several key conclusions:
Promising Therapeutic Potential: Studies suggest that 40 Hz stimulation has promising therapeutic potential for Alzheimer’s disease. By externally inducing gamma oscillations at this frequency, researchers aim to improve cognitive function and potentially slow the progression of the disease.
Effects on Neural Activity: Research has shown that 40 Hz stimulation can modulate neural activity, particularly in brain regions associated with memory and cognitive function. This modulation may help restore aberrant neural circuits and synaptic plasticity observed in Alzheimer’s disease.
Preclinical Efficacy: Preclinical studies, including those conducted in mouse models of Alzheimer’s, have demonstrated positive effects of 40 Hz stimulation on memory, synaptic function, and amyloid-beta pathology. These findings support further exploration of this intervention in clinical settings.
Mechanistic Insights: MIT’s research has provided valuable insights into the underlying mechanisms by which 40 Hz stimulation may exert its therapeutic effects in Alzheimer’s disease. This includes effects on neural circuitry, synaptic plasticity, and clearance of amyloid-beta plaques.
Human Trials: MIT has been involved in human trials to assess the safety and efficacy of 40 Hz stimulation in individuals with Alzheimer’s disease. While results from these trials are still emerging, initial findings suggest potential benefits for cognitive function and disease progression. A pair of early-stage clinical studies testing the safety and efficacy of 40-hertz sensory stimulation to treat Alzheimer’s disease has found that the potential therapy was well-tolerated, produced no serious adverse effects, and was associated with some significant neurological and behavioral benefits among a small cohort of participants.
Conclusion
Overall, MIT’s studies on 40 Hz stimulation and Alzheimer’s disease highlight the importance of gamma frequency oscillations in cognitive function and the potential of targeted stimulation as a therapeutic approach for Alzheimer’s disease.
Most recently, in pilot clinical studies the team showed that 40 Hz light and sound stimulation was safe, successfully increased brain activity and connectivity, and appeared to produce significant clinical benefits in a small cohort of human volunteers with early-stage Alzheimer’s disease. Other groups have replicated and corroborated health benefits of 40 Hz sensory stimulation.
Latest News is even Better ~ March 3, 2025
Review: Evidence expanding that 40Hz gamma stimulation promotes brain health
Indeed the review points to studies at MIT and other institutions providing at least some evidence that GENUS might be able to help with Parkinson’s disease, stroke, anxiety, epilepsy, and the cognitive side effects of chemotherapy and conditions that reduce myelin such as multiple sclerosis. Tsai’s lab has been studying whether it can help with Down syndrome as well.
You don’t need to visit MIT to get 40 Hz Alzheimer Therapy
SAVE $100. NOW ONLY $299 FOR A LIMITED TIME
Get your VIBE now
SAVE $100. NOW ONLY $299 FOR A LIMITED TIME
Get your VIBE now
References
40 hz Vibrations Reduce Alzheimers Pathology Symptoms
Small studies 40hz Sensory stimulation confirm safety Suggest Alzheimers Benefit
How 40Hz sensory gamma rhythm stimulation clears amyloid in Alzheimer's mice
Evidence Gamma Rhythm Stimulation can treat Neurological Disorders emerging
Stimulating the brain at 40 Hz to treat Alzheimer’s disease
Study reveals ways which 40hz Sensory Stimulation May Preserve Brains White Matter
Evoking neuronal activity to improve the lives of Alzheimer’s patients
Review: Evidence expanding that 40Hz gamma stimulation promotes brain health
Indeed the review points to studies at MIT and other institutions providing at least some evidence that GENUS might be able to help with Parkinson’s disease, stroke, anxiety, epilepsy, and the cognitive side effects of chemotherapy and conditions that reduce myelin such as multiple sclerosis. Tsai’s lab has been studying whether it can help with Down syndrome as well.
You don’t need to visit MIT to get 40 Hz Alzheimer Therapy
SAVE $100. NOW ONLY $299 FOR A LIMITED TIME
Get your VIBE now
All Resona Health products are FDA general wellness devices. We do NOT treat, diagnose, prevent, or cure any disease nor do we make ANY claims in this manner.
RSS Feed
